Department of Dermatology and Venereology, Ankara University, Ankara, Turkey.
Department of Dermatology, Koç University, Istanbul, Turkey.
Br J Dermatol. 2019 Jun;180(6):1459-1467. doi: 10.1111/bjd.17466. Epub 2019 Feb 20.
Hidradenitis suppurativa (HS) is a rare, debilitating neutrophilic dermatosis characterized by chronic inflammation of hair follicles. Many inflammatory conditions may accompany HS.
To investigate the association of variants of the MEFV gene with a complex HS phenotype.
Firstly, we identified the clinical characteristics of 119 patients with HS with a complex phenotype (Hurley stage III disease and/or additional inflammatory symptoms). Then, we searched for MEFV variants among these patients. The odds ratios (ORs) for pathogenic MEFV mutations were calculated using data from these patients with HS and 191 healthy controls.
The male/female ratio was higher, and the mean age of onset was earlier, in our complex HS group compared with patients with HS in general. Five of the patients with HS (4·2%) had a diagnosis of familial Mediterranean fever (FMF) with a standardized morbidity ratio of 45 [95% confidence interval (CI) 16·50-99·84, P < 0·001] when compared with the frequency of FMF in the general Turkish population. Of the patients with complex HS, 38% were positive for pathogenic variants of MEFV. The OR for carrying a pathogenic MEFV allele was 2·80 (95% CI 1·31-5·97, P < 0·001).
The frequency of MEFV mutations in the group of patients with complex HS was higher than that in healthy controls, suggesting that MEFV mutations may contribute to the pathogenesis of HS. Understanding the role of autoinflammation in HS is of fundamental importance for the development of novel therapies.
化脓性汗腺炎(HS)是一种罕见的、使人衰弱的中性粒细胞皮肤病,其特征为毛囊的慢性炎症。许多炎症性疾病可能伴有 HS。
研究 MEFV 基因突变与复杂 HS 表型的相关性。
首先,我们确定了 119 例具有复杂表型(Hurley 分期 III 期疾病和/或其他炎症症状)的 HS 患者的临床特征。然后,我们在这些 HS 患者中寻找 MEFV 变异。使用来自这些 HS 患者和 191 名健康对照的数据计算致病性 MEFV 突变的优势比(OR)。
与一般 HS 患者相比,我们的复杂 HS 组的男女比例更高,发病年龄更早。5 例 HS 患者(4.2%)被诊断为家族性地中海热(FMF),标准化发病比为 45[95%置信区间(CI)16.50-99.84,P<0.001],与一般土耳其人群中 FMF 的频率相比。在复杂 HS 患者中,38%的人存在 MEFV 致病性变异。携带致病性 MEFV 等位基因的 OR 为 2.80(95%CI 1.31-5.97,P<0.001)。
复杂 HS 组患者 MEFV 突变的频率高于健康对照组,提示 MEFV 突变可能参与 HS 的发病机制。了解自身炎症在 HS 中的作用对开发新的治疗方法具有重要意义。